Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG20064)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
hsa-miR-670-3p
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Long-chain-fatty-acid--CoA ligase 4 (ACSL4) [Driver]
In total 1 item(s) under this target | ||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
Target for Ferroptosis | Driver | |||
Responsed Disease | Glioblastoma | ICD-11: 2A00 | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
U-87MG cells | Glioblastoma | Homo sapiens | CVCL_GP63 |
A-172 cells | Glioblastoma | Homo sapiens | CVCL_0131 | |
SVG p12 cells | Normal | Homo sapiens | CVCL_3797 | |
hMGCs (Human normal brain astroglia cells) | ||||
Response regulation | miR-670-3p level was elevated in human glioblastoma, but decreased upon ferroptotic stimulation. Mechanistically, ACSL4 was required for the regulation on ferroptosis and growth of glioblastoma cells by miR-670-3p. Moreover, U87MG and A172 cells treated with miR-670-3p inhibitor showed an increased chemosensitivity to TMZ. | |||
Glioblastoma [ICD-11: 2A00]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
Target Regulator | hsa-miR-670-3p (miRNA) | miRNA | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Cell Process | Cell ferroptosis | |||
Cell proliferation | ||||
In Vitro Model |
U-87MG cells | Glioblastoma | Homo sapiens | CVCL_GP63 |
A-172 cells | Glioblastoma | Homo sapiens | CVCL_0131 | |
SVG p12 cells | Normal | Homo sapiens | CVCL_3797 | |
hMGCs (Human normal brain astroglia cells) | ||||
Response regulation | miR-670-3p level was elevated in human glioblastoma, but decreased upon ferroptotic stimulation. Mechanistically, ACSL4 was required for the regulation on ferroptosis and growth of glioblastoma cells by miR-670-3p. Moreover, U87MG and A172 cells treated with miR-670-3p inhibitor showed an increased chemosensitivity to TMZ. | |||